Blue Horseshoe Stocks: LXRX Recap & Much More

Lexicon Pharmaceuticals, Inc. LXRX

Our first order of business today is to congratulate any of our readers who were able to turn our premarket alert of LXRX into hefty intraday gains.

We were given ample opportunity to do so, as a hugely significant PR left the stock positively charged for most of the session. A momentous intraday run began from an early low of 10.83 and topped out at an HOD of 13.80. That translates to a 27% jump, which is a very impressive single-session performance for a $10 stock.

If you recall, we hit this one from multiple angles; our options trading idea of tracking Weekly $10 Calls was also good for potential profits. Those contracts traded up from a low of 1.50 all the way to 3.90, which was good for gains of up to 160%

LXRX held the majority of its daily advance, which occurred on well over 30-times the 3-month average volume. That sets the stock up with plenty of momentum, and signals us to keep an eye out in coming sessions for a continuation of such. In the event that occurs, as far as options are concerned, we’d roll our strike price up to the Weekly $12.50 Calls, which already made a heck of a move yesterday from .45-2.00.


Hutchinson Technology, Inc. HTCH

We also want to give a quick update on HTCH, which we entered into the conversation via Friday’s premarket report. We witnessed the beginning of its run that day with a low of 1.60, and subsequent 22% pop to 1.95.

Yesterday, the stock set a new high of 2.25, which marked a two-day increase of 41% In order for us to remain interested in this play. we’ll need to see it continue to record higher lows.

Super-Subpenny Bottom-Watchlist

Here are a couple of stocks trading in the triple-zero range that we thought were worthy of compiling into a potential bottom-play watchlist as we head into midweek. We’ll include charts for the pair illustrating the reasoning behind that:

  Pervasip Corp. PVSP

B2Digital, Inc. BTDG

Extended Watchlist:

S, FIT($50-51 Weekly Calls), DAL, AAPL(Radar for Eventual Bounce)

Blue Horseshoe Stocks: Friday Recap & New Interests

Recapping Friday’s Interests

Friday’s session bore some nice opportunities among the plays we were discussing in our premarket report, from both options and stocks.

Our top options target turned out to be Expedia, Inc. EXPE, in which we were tracking the Weekly $115-117 Calls. Every one of the contracts in that range produced chances for multi-bag gains:

$115 Calls - Daily Range: 1.12-5.04 – Max Gain: 350%
$116 Calls - Daily Range: 1.32-6.40 – Max Gain: 385%
$117 Calls - Daily Range: .87-4.12 – Max Gain: 374%


On the stock side of things, we were observing Hutchinson Technology, Inc. HTCH which had caught our eye on a routine premarket scan for abnormal activity. The stock responded with a solid session to close out the week, trading from a low of 1.60, and reaching as high as 1.95; a respectable 22% intraday move.

We also wanted to say a quick word about Wizard World, Inc. WIZD, which we called as a potential bottom-play after noticing the stock tumbling to new 52-wk lows. The stock managed to make a nominal 18% intraday jump off of that bottom, so we’ll watch for the possibility of a protracted recovery. We’ll look for WIZD to continue to register higher lows.

Mobile Broadcasting Holding, Inc. MBHC

MBHC responded well to Friday’s news regarding the findings of beta testing on its upcoming app (View PR), as it continued to build a higher base of support off of the .0042 swing-low that it recorded last Tuesday.

We watched the stock trade in a range from .0052 to .006 (+15%), and that high marked an overall four-session move of 43%  It drew back slightly to close at .0057, the point from which we’ll look to see it continue to log higher lows as we commence a new trading week.

We’ve prepared a video highlighting the key points of the MBHC chart:

Fresh News Plays

Lexicon Pharmaceuticals, Inc. LXRX is gapping up heavily this morning after the company published an early-morning PR announcing that its Phase III cancer treatment has met primary endpoints. We can look for short-term opportunities in the stock itself, and in the options chain, where we’ll monitor $10 Calls. Be on the lookout for a possible dip-and-rip scenario!

Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome (Mon 1:01AM EDT)

Mixx 1 Life, Inc. MIXX is also piquing our interest with a premarket PR and its positioning on the chart as a good bottom-watch candidate The stock has fallen dramatically to new 52-week lows, and is looking extremely oversold. The CEO has released a letter to shareholders today addressing the extreme conditions, and we’re going to slate this one for observation as the potential recovery could produce some serious chances for profit.

Blue Horseshoe Stocks: Pharma Watchlist & More

Lexicon Pharmaceuticals, Inc. LXRX

We’re taking notice of LXRX this morning in the wake of a premarket PR that has the stock trending up to its highest levels of the past three months; it contained updates on current projects as well as increased earnings. The addition of an interesting setup on the chart gives us good reason to place LXRX on watch this mid-week.

As you can see on the snapshot below, the stock gapped down significantly at the end of November. In premarket activity today we’re seeing a partial fill taking place. We’re going to be watching for LXRX to fill the remainder of the gap into the mid 1.20′s where its next area of resistance will come in at the 200DMA of 1.28.

THE WOODLANDS, Texas, March 4, 2015 /PRNewswire/ – Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.>> VIEW PR

Pharmaceutical Watchlist

There are a number of other pharma and biopharma stocks gapping up in the premarket this morning, some of which have appeared in our reports in the past. We’ve listed them below along with links to today’s news, where applicable:

Keryx Biopharmaceuticals, Inc. KERX

Atossa Genetics, Inc. ATOS

Coronado Biosciences, Inc. CNDO

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies (Wed 8:30AM EST)

PhotoMedex, Inc. PHMD

Orexigen Therapeutics, Inc. OREX

KaloBios Pharmaceuticals, Inc. KBIO

Earnings-Related Options Ideas

American Eagle Outfitters, Inc. AEO beat expected Q4 profits and revenues, and is gapping up as a result. To take advantage of the trend, we are monitoring options trading possibilities in the AEO Weekly $15-16 Calls

Abercrombie & Fitch ANF fell short of expectations with regard to sales, which is fueling a downtrend here in the premarket, so we’ll take the opposite approach here, and keep an eye on ANF Weekly $23-24 Puts.

Extended Watchlist:

Blue Horseshoe Stocks: HEMP, TTDZ, PBR

Hemp, Inc. HEMP

Since 2012, we’ve talked up the business side of marijuana, and with all that has happened in the space since then, we have not been disappointed.

Our long-term subscribers recall that HEMP was among the first pot plays that we ever discussed, with its appearances in our reports dating all the way back to 10/16/12. If you take a look at our HEMP archive, you will find pages upon pages of coverage spanning from then up to the present, and it has been one heck of a ride.

When it first came across our screens, we saw two major runs from HEMP at the end of 2012 and leading into 2013, spanning from the .03-range up to .09, and from just below .03 back to a dime, respectively.

Flash forward to this past December, when HEMP had come all the way down under a penny (as low as .0085). Even though we knew the cannabis sector was bound to be huge, nothing could have prepared us for what was to come. As you all know, pot stocks across the board absolutely exploded around the New Year, and it sent HEMP on a stratospheric run which culminated in a high of .34 (Feb 5th.). The overall move we saw out of this play was a staggering 3900% between 12/19/13-02/05/14.

The following chart shows both that huge run, and current conditions that have us standing at attention. The PPS is holding support at a key level of previous resistance, and the MACD indicator is priming up for a bullish move:

Also turning our focus to HEMP today is the fact that just this morning, the company has released record-setting quarterly financials:

“Total sales for first quarter 2014 represent an increase of 1,181% over the same quarter last year and a marked 656% increase over the previous quarter announced just days ago.”  >> Go To PR

Triton Distribution Systems, Inc. TTDZ

Despite the general pullbacks throughout pot sector last week (perhaps largely related to the SEC’s temporary halt of PHOT) TTDZ managed to close out the week on a high note. On Friday, the stock made a nice intraday move from .024 to .0419, giving folks the chance at up to 75% in gains.

The last time we touched upon this favorite of ours, was last Monday, when we were congratulating ourselves for having seen a new high (.04) from TTDZ. The next day, the stock pushed the envelope again, setting yet another high mark at .049. From our first alert on January 30th (at a price of .0012), that is equal to an increase of 3983%

Petroleo Brasiliero S.A. (Petrobras) PBR

PBR and its options chain has been a veritable goldmine for us in recent weeks, and last week was no exception. We even saw a partial fill of the gap on the chart that we have been eyeing since beginning coverage on this play.

We were heavily interested in the $13.50 and $14 Weekly Calls for intra-week flip opportunities, and there were indeed many chances to profit.

We’re still currently looking at the $14 & $14.50 Weekly Calls for more potential flip opportunities.

The longer-term targets we’ve been tracking are the May $12 and the April $14′s, which, after already providing huge gains, still hold our interest.

Extended Watchlist:

IWEB, ZLCS & Extended Watchlist

Most of you will recall our coverage of IWEB, which began on July 9thand lasted through August. During that time, we saw the stock make a nice move off of its then-52 week lows, traversing its way from a low of .023 all the way up to .042, an 83% overall move, while also posting several hundred percent in cumulative gains during that time.You might also remember our outlining of the company’s aspirations to make the shift from cloud storage alone, to a full-range cloud services provider, and today, we received confirmation that the transition has been achieved, with the completion of the company’s most recent acquisition.

This is occurring shortly after we’ve seen IWEB come off of a new 52-week low, so the timing on this could actually work in our favor. We are going to have IWEB on bottom-watch as it searches for a base here, as well as watching for reaction to the good things the company obviously has going on behind the scenes.

STERLING, Va., Oct 01, 2013 (BUSINESS WIRE) — IceWEB, Inc. – (OTC BB:IWEB), today announced that it has completed its acquisition of Computers and Tele-Comm, Inc. and KC-NAP, LLC of Kansas City (collectively “CTC”). Details will be filed in a Form 8-K with the Securities and Exchange Commission. >>> FULL STORY

More Info:

Zalicus, Inc. ZLCS

We caught ZLCS at a low of .78 last Friday, and mentioned it once again yesterday morning as we believed the stock was in for “another substantial move upward”. The stock did indeed turn in a nice performance yesterday, hitting a high of 1.20, a 17% intraday move, and an increase of 54% from Friday’s low. Rapid increases over such a short time period for a NASDAQ-traded stock are impressive to say the least.

In addition to another fruitful trading session with regard to price-per-share, ZLCS landed us an honorable mention on yesterday’s Penny Stock Rumble for picking the stock with the highest daily dollar volume.

Extended Watchlist: